The surrogate light chain (SL) is composed of two polypeptides, V pre-B and λ5. In large pre-BII cells the SL chain associates with Ig µ heavy chain (µH) to form the pre-B cell receptor (pre-BCR). In mice there are two V pre-B genes which are 98% identical within the coding regions. The two genes are co-expressed at the RNA level and encode functional proteins that can assemble with λ5. However, it is not known whether both gene products serve the same function in vivo. Here 
Introduction
The λ5 and V pre-B genes are expressed early in B lymphocyte development, i.e. in pro-B/pre-BI and large pre-BII cells (1) (2) (3) (4) (5) (6) . Together they encode the surrogate light chain (SL) chain, which has distinct homologies to conventional Ig chains (7) . In pro-/pre-BI cells the SL chain associates with a complex of glycoproteins; however, its function at this stage of development is not yet clear (8) . In the large pre-BII cell stage the SL chain associates with the Ig µ heavy (µH) chain and forms the pre-B cell receptor (pre-BCR) (9, 10) . Experiments in which either the transmembrane part of µH or the λ5 gene has been disrupted show that the pre-BCR affects the expansion of large pre-BII cells into more mature B cell compartments (11, 12) .
In mice, the λ5 chain is encoded by a single gene, whereas the V pre-B chain is encoded by two genes (3, 13) . The two V pre-B genes are almost identical; only 9 bp difference in the coding regions causing a difference of 4 amino acids between the two polypeptides (3, 7) . On the mRNA level, expression of the V pre-B1 gene has been detected in all pre-BI and pre-BII bone marrow cells, while V pre-B2 was only found in some of the same pre-BI and pre-BII cells. This, however, might be due to a difference in detection levels (6) . Both genes encode functional proteins that can assemble with λ5 when expressed in COS cells (6) . Due to the high degree of homology it is not known if both V pre-B proteins are present in pre-BI and pre-BII cells. In this study we analyze how the lack of a functional V pre-B1 gene affects B lymphocyte development. Homologous integration was detected using EcoRI-digested DNA and a probe positioned 3Ј outside the vector. The targeted locus would give rise to a band of 7.2 kb in size instead of the 9.6 kb nontargeted allele. Restriction enzyme sites: K, KpnI; M, MboI; X, XbaI; R, EcoRI; Pv, PvuII; 'Pv', destroyed PvuII site; Ps, PstI; B, BamHI. (B) Southern blot to distinguish the targeted locus. The genomic DNAs were digested with EcoRI. Lanes 1-8; the E14 embryonic stem cell line, the positive Y2 clone, mouse #129 (ϩ/ϩ), mouse #128 (ϩ/-), mouse #127 (-/-), mouse #120 (ϩ/ϩ), mouse #119 (ϩ/-), mouse #118 (-/-). Mice #127-129 are littermates as are #118-120.
Methods

DNA constructs
All DNA constructs were made using conventional DNA techniques (14) . The V pre-B1 targeting construct was made in several steps using subcloned fragments from the phage 7pB12 (13) . The final construct contained the following in 5Ј to 3Ј order ( Fig. 1 
Embryonic stem cells and transfections
The procedure has been described before (12) . Briefly, the embryonic stem cell line E14 was grown in Iscove's medium supplemented with 2-mercaptoethanol, MEM, antibiotics, LIF (0.1%) and 15% FSC (Boehringer). The LIF was harvested from CHO-LIF cells. Tissue culture plates were gelatinized with 0.1% gelatine after which a layer of G418-resistant embryonic fibroblasts was plated. The fibroblasts were irradiated with 3000 rad before adding the embryonic stem cells.
The embryonic stem cells were used at 10 7 cells per transfection event. The cells were transfected by electroporation and after~36 h selected in 0.2 mg (active) G418/ml. Resistant colonies were picked, expanded and frozen. Parallel cultures, in the absence of feeder cells, were set up for preparation of genomic DNA.
Screening of positive embryonic stem cell clones
Genomic DNA from individual clones were screened by Southern blotting. The DNA was digested with KpnI. The probe used was derived from a region outside the construct. Positive colonies were confirmed by digestion with EcoRI using a probe not contained in the targeting construct ( Fig.  1 ; probe, 1.9 kb BamHI-KpnI fragment). Clone Y2, which was later used to establish mice, was further confirmed by several other restriction enzyme digests.
Mice
The Y2 clone was used to establish chimeric mice, using blastocysts from C57Bl/6. The male chimeras were bred with C57Bl/6 females, and heterozygous and homozygous mice were established. After this the mice were interbred. The C57Bl/6 mice were obtained from Bomholtgaard (Ry, Denmark).
Screening tail DNA for genotype
Tail DNA was prepared as described (12) . To distinguish between wild-type, heterozygous and homozygous mice we used Southern blotting as described above or a PCR assay in which a mixture of 3 primers (VpB1 sense, VpB1 antisense and neo sense) were used. The thermal cycling profile was: 94°C, 20 s; 62°C, 20 s; 72°C, 30 s for 30 cycles. Under these conditions the wild-type allele gives rise to a 430 bp fragment and the disrupted allele yields a 230 bp fragment.
Oligonucleotides
The oligonucleotides used were as follows. neo sense: 5Ј-AAGGCACCTTGGAGGTAATGCAT-3Ј. HGPRT sense: GCTG-GTGAAAAGGACCTCT. HGPRT anti-sense: 5Ј-CACAGGACT-AGAACACCTGC. The V pre-B1 , V pre-B2 and λ5 primers have been described before (6) .
RNA isolation and RT-PCR
Total RNA from bone marrow cells was isolated using Ultraspec and conditions according to the manufacturer (Ultraspec; Biotec). First-strand cDNAs were synthesized from 1 µg total RNA by reverse transcription with random primers and these cDNAs were used as templates in PCR reactions (14) using a DNA thermal cycler (Perkin-Elmer, Foster City, CA) with Taq polymerase from Gibco/BRL (Bethesda, MD). Differential amplification of specific V pre-B1 and V pre-B2 transcripts was performed as described (6) . Samples were also assayed for level of HGPRT transcripts, as a control for the quality and quantity of RNA. Also λ5 message was analyzed to confirm that it was not affected by the V pre-B1 deletion or by the insertion of the neo-resistance gene. The λ5 message was detected as described before (6).
Pre-B cell cultures
Pre-B cells from bone marrow of the indicated mice ( Fig. 3 ) were cultured for 6-7 days as described (15) . Briefly,~25-50ϫ10 3 total bone marrow cells were plated in 24-well plates on γ-irradiated ST2 stromal cells in the presence of 100 U IL-7/ml (16) . The cells were cultured in IMDM-supplemented with 2-mercaptoethanol, antibiotics and 5% heat-inactivated FCS.
Flow cytometric analysis
Single-cell suspensions from bone marrow were prepared by flushing out cells from femurs with ice-cold staining buffer (HBSS containing 3% FCS). Spleen, lymph node and thymus cells in single-cell suspensions were stained with the antibodies described below and then analyzed by flow cytometry (FACS) using a FACSort (Becton Dickinson). The cells were gated on the extended lymphocyte gate and then analyzed for reactivity with mAb as described (17, 18 Immunizations and ELISA
Wild-type, heterozygous and homozygous mice (four to five mice in each group) were immunized i.p. with 100 µg of the T-dependent antigen phenyl-oxazolone coupled to ovalbumin as alum precipitate. Two weeks later sera were collected and analyzed for the presence of hapten-specific (plates coated with phenyl-oxazolone coupled to BSA) or carrier-specific (ovalbumin) antibodies in ELISA.
Results
Establishment of V pre-B1 -deficient mice
To analyze the role of V pre-B1 and V pre-B2 in B cell development we set out to establish mice lacking the germline V pre-B1 gene.
Comparing the restriction enzyme maps of the two V pre-B genes shows that the homology between the two extends no further than a few hundred base pairs 5Ј and 3Ј of the coding regions (6) . Therefore, a vector that would disrupt the V pre-B1 gene would not be expected to integrate at the V pre-B2 locus at this frequency. A vector to replace the V pre-B1 gene with the gene encoding neomycin resistance was constructed as shown in Fig. 1(A) . Embryonic stem cells were transfected and G418-resistant clones screened for homologous recombination. One clone, Y2, out of 352 analyzed was found to carry a disrupted V pre-B1 gene on one allele and was therefore used to establish mice homozygous for the deletion in the V pre-B1 gene (VpB1 -/-). A Southern blot is shown in Fig. 1 (B) in which EcoRI-digested DNA from several sources was analyzed by hybridization with the 1.9 kb probe in Fig. 1(A) . The E14 embryonic stem cell line shows one band of~9.6 kb, while the Y2 clone shows two bands, one of which is 9.6 kb and the other is 7.2 kb. The latter band corresponds to the disrupted V pre-B1 allele. In the same figure is shown DNA from individual mice, some of which are wild-type (ϩ/ϩ), heterozygous (ϩ/-) and homozygous (-/-). Thus, the Y2 embryonic stem cell clone gave rise to mice with a deletion in the V pre-B1 gene.
Presence of V pre-B2 but not V pre-B1 RNA
To confirm that the mutation abolished expression of V pre-B1 transcripts, bone marrow RNA was prepared from the mice analyzed in Fig. 1 . The RNAs were analyzed in a RT-PCRbased assay which distinguishes between V pre-B1 and V pre-B2 mRNA (6) . As seen in Fig. 2 , V pre-B1 wild-type (ϩ/ϩ), heterozygous (ϩ/-) and homozygous mutant (-/-) mice all made V pre-B2 mRNA. However, V pre-B1 transcripts could not be detected in V pre-B1 -/-mice, while they were found in both the wild-type and heterozygous mutant mice, as expected. PCR of V pre-B1 or V pre-B2 produced two bands, the larger of which corresponds to either genomic DNA or unspliced RNA (the primers span the 87 bp intron). Note that V pre-B1 -/-mice also lacked this band when V pre-B1 , but not V pre-B2 expression was examined (cf. Fig. 2, lanes 10 and 14) . Since the V pre-B1 sense primer is situated in the region that was deleted upon homologous recombination, this provided additional evidence that this part of the V pre-B1 gene had been deleted. The same cDNA preparations were also analyzed for the presence of λ5 (and HGPRT) message and similar levels were detected in all mice. This demonstrates that expression of the λ5 gene was not affected by the V pre-B1 deletion or by the insertion of the neo resistance gene into the V pre-B1 locus which is located 4-5 kb upstream of the λ5 gene. Thus, the targeting vector disrupted the V pre-B1 gene and prevented its expression but did not alter expression of λ5 or V pre-B2 .
The V pre-B2 gene encodes a functional protein Earlier experiments showed that both V pre-B1 and V pre-B2 could associate with λ5 to form a SL chain (6) . Since the V pre-B2 , but not the V pre-B1 , gene was expressed in the mutant mice we investigated if V pre-B2 was present on the cell surface of bone marrow-derived pre-B cells cultured in vitro (15) . After 6 days in culture on stromal cells, in the presence of IL-7, the cells were analyzed by FACS after staining for expression of B220 (CD45R) versus an antibody (VP245) that recognizes both the V pre-B1 and V pre-B2 proteins or an isotype-matched control antibody (6, 8) . The cells in the lymphocyte gate were large and 99% stained positive for B220 (data not shown). Figure 3 shows that the VP245 antibody recognized a cell surface bound V pre-B protein in cells from both V pre-B1 heterozygous and homozygous mutant mice which, in the latter case, corresponds to only V pre-B2 . Thus, as suggested earlier (6), the V pre-B2 gene encodes a functional protein that can be expressed on the cell surface of pre-B cells.
Partial block at the transition into the pre-BCR stage
To determine whether the failure to express V pre-B1 had any effect on B cell development we first analyzed the spleen of V pre-B1 -/-mice. Here, we found that the total number of cells, and the percentages of cells expressing B220, IgM, CD8 and CD4 were about normal, suggesting that the peripheral B and T cell compartments were not affected (data not shown). We then analyzed B220 and IgM expressing B cells in lymph nodes which showed the same pattern in all three genotypes (data not shown). Lastly, analysis of thymus demonstrated a normal pattern of CD4 and CD8 positive cells (data not shown). Thus, spleen, lymph node and thymus in the V pre-B1 -deficient mice were normal in terms of B and T lymphocytes.
Since SL chain is expressed and functions specifically at early stages of B cell development, bone marrow cells were analyzed by different means. The cells were counted and the number of nucleated cells in homozygous mutant mice was found to be similar to that of wild-type and heterozygous mutant mice. Thereafter cells were analyzed for expression of B220 in combination with either IgM, CD25, CD43 or CD117 (c-kit). The differential expression of these markers is characteristic of their differentiation stage (17, 18) . The percentage of cells expressing B220 was found to be~50% in all three genotypes. As shown in Fig. 4(A) , the homozygous mutant mice stained positive for B220 in combination with all the above-mentioned markers. However, the percentage of cells in the various compartments differed in V pre-B1 -/-mice as compared to heterozygous and wild-type mice: the B220 ϩ c-kit ϩ and B220 ϩ CD43 ϩ compartments were increased, while the B220 ϩ CD25 ϩ and B220 ϩ IgM ϩ compartments were slightly decreased.
To more closely analyze these differences, bone marrow cells that expressed low to intermediate levels of B220 (B220 lo/int ) were analyzed further (B220 high cells are recirculating cells). The B220 lo/int cells were gated (Fig. 4B, gate R2 ) and the percentage of cells within this gate that expressed the above markers determined (Fig. 4B, M1 ). As shown in the histograms in Fig. 4(C) and the summary in Fig. 4(D) , the percentage of B220 lo/int IgM ϩ cells was slightly decreased in V pre-B1 -/-mice. The same result was also observed for B220 lo/ int CD25 ϩ cells (Fig. 4C and data not shown) . In contrast, the percentage of B220 lo/int CD117 ϩ cells was~2-fold higher in homozygous as compared to heterozygous mutant mice. This was also the case for B220 lo/int CD43 ϩ cells. A summary of several experiments, which also included wild-type mice, is shown in Fig. 4(D) . Since the number of bone marrow cells in all three genotypes was about the same, the increase in the percentage of B220 lo/int CD117 ϩ cells represented an increase in the actual number of B220 lo/int CD117 ϩ cells. The size distribution among the cells that expressed either CD117, CD43, CD25 or IgM was similar among the three genotypes, suggesting that the lack of V pre-B1 did not affect the expression of these markers per se (Fig. 4E and data not shown) . Thus, the number of bone marrow cells expressing B220 lo/int in combination with CD117 and CD43 was enriched for by a factor of 2, while B220 lo/int CD25 ϩ and B220 lo/int IgM ϩ cells were each decreased by~20% in V pre-B1 -/-mice. Pre-BI cells express B220, CD117 and CD43 but not CD25; pre-BII cells are B220 ϩ CD25 ϩ but lack c-kit and CD43. The CD25 marker is not found on more differentiated cells, i.e. immature and mature B cells (18) . Large pre-BII cells that express a functional pre-BCR are expanded by proliferation and, upon differentiation, give rise to small pre-BII cells. Among the B220 lo/int CD25 ϩ cells~20 and 80% constituted large and small cells respectively in all three genotypes (Fig.  4E and data not shown) . This suggested that cells with a functional pre-BCR were expanded also in the marrow of V pre-B1 homozygous mutant mice. Thus, bone marrow from V pre-B1 -/-mice exhibited an enrichment in pre-BI cells (B220 lo/ int CD117 ϩ CD43 ϩ ) and a reduction in large pre-BII cells (B220 lo/int CD25 ϩ ) suggesting that the lack of V pre-B1 affected B lymphocyte development at the transition into the pre-BCR stage.
Ig allelic exclusion in V preB1 -deficient mice To determine if the V pre-B2 -containing pre-BCR was functional in terms of allelic exclusion of the Ig loci, we analyzed spleen and bone marrow cells by FACS for the presence of both Ig allotypes in Ig a /Ig b heterozygous mice. As shown in Fig. 5 , Ͼ98% of all sIgM ϩ B cells of bone marrow and of spleen from V preB1 -/-Ig allotype heterozygous mice expressed either one or the other, but not both Ig allotypes on one cell. Thus, a defective V pre-B1 gene did not affect Ig allelic exclusion.
Normal immune response against T-dependent antigens
We next examined the ability of V pre-B1 -deficient mice to mount a T-dependent antigen response by immunizing with the Downloaded from https://academic.oup.com/intimm/article-abstract/11/3/453/777174 by guest on 22 November 2018 Fig. 6 . Normal immune response to a T-dependent antigen. V pre-B1 wild-type (ϩ/ϩ), heterozygous (ϩ/-) and homozygous (-/-) mutant mice were immunized (i.p.) with 100 µg alum precipitate of the Tdependent antigen phenyl-oxazolone coupled to ovalbumin as a carrier. Two weeks later sera were taken and analyzed for hapten (Ox)-specific antibodies in ELISA. Each group contained four or five mice. Shown is the titer of each serum at 50% of the plateau level. Sera from non-immunized mice: Ͻ1.
hapten phenyl-oxazolone coupled to the carrier ovalbumin. Two weeks after immunization, serum were tested in ELISA for the presence of hapten-and carrier-specific antibodies. As shown in Fig. 6 , all mice showed a good response to the hapten, independent of the status of the V pre-B1 loci. The response to the ovalbumin carrier was also normal in all mice (data not shown). Therefore, the absence of V pre-B1 did not alter the immune response to T-dependent antigens.
Discussion
Our aim here was to evaluate the role in B lymphocyte development of one of the two V pre-B genes present in the mouse genome, i.e. the V pre-B1 gene. We find that disruption of the V pre-B1 gene causes a partial block in B cell development at the transition into the pre-BCR stage as defined by an increase in the number of pre-BI cells and a slight decrease in the number of large pre-BII cells. However, the number of mature B cells in the periphery was not affected. Moreover, allelic exclusion of IgH gene expression, in the central and peripheral B cell compartments, is functional as are T celldependent immune responses. This demonstrates that both V pre-B gene products are functional and involved in the formation of the pre-BCR. It also shows that V pre-B2 alone is sufficient, but not as efficient as the two genes together, in supporting B lymphocyte development.
We showed earlier that the expression pattern at the RNA level of the two V pre-B genes (and λ5) is similar in fetal liver cells and in pro-B/pre-BI and large pre-BII bone marrow cells. Single-cell RT-PCR of the latter two populations detected V pre-B1 (and λ5) mRNA in all cells, but V pre-B2 transcripts were found in only a portion (30%) of the same cells (6) . This discrepancy was proposed to be due to a difference in sensitivity of the primer pairs used in the assays, a hypothesis which is supported by our results herein: the number of large pre-BII cells in V pre-B1 -/-mice is too high to be derived from only one-third of the normal numbers of pre-BI cells. In transfection experiments, both V pre-B gene products have been shown to assemble with the λ5 protein. However, it is not known if they do so in vivo since there is no antibody described that distinguishes the two V pre-B proteins (6, 20) . Our results here demonstrate that the V pre-B2 gene product can be incorporated in both the pro-B and pre-B cell receptors of pro-B/pre-BI and large pre-BII bone marrow cells. Furthermore, V pre-B2 can function in all steps of development, especially in the pre-BCR-dependent proliferative expansion of large pre-BII cells. If the pre-BCR is also involved in allelic exclusion of the IgH chain gene expression, then V pre-B2 in pre-BCR can also do that.
The importance of the membrane form of the µH chain and the λ5 gene product at the pre-BCR stage was demonstrated earlier in mice lacking the respective gene product (11, 12) . Here we show that also the V pre-B1 gene product is important at the pre-BCR stage since the lack of V pre-B1 causes an enrichment of cells at the pre-BI stage, i.e. a partial block at the transition into the pre-BCR stage. It has recently been shown that not all Ig µH chains made from productively VDJ Hrearranged IgH loci can pair with the SL chain (21) . Cells expressing such non-pairing µH chains cannot form a pre-BCR and do not participate in the proliferative expansion of large pre-BII cells. Hence, cells expressing these µH chains do not appear in the subsequent pre-B and B cell repertoires. Some of the inability to pair may well be due to a structural incompatibility of a V H domain in interactions with V pre-B . If so, then pairing to V pre-B1 and V pre-B2 may differ since some of the nucleotide differences between the two V pre-B genes encode amino acid replacements. The V H repertoires of normal and V pre-B1 -/-mice may, therefore, differ. This will be investigated in future experiments.
The cells that progress through the pre-BCR stage in V pre-B1 -/-mice seem to be normal in that they are expanded by proliferation, and the number of more mature cells is just slightly decreased as compared to heterozygous mutant and wild-type mice. This did not significantly affect the number of B cells detected in the periphery. This is in agreement with experiments that showed that a minor decrease in the production of pre-B cells (here pre-BII) in the marrow did not affect the number of B cells in the periphery, while a major decrease in pre-B cells did (22) . Such a minor decrease in pre-B cells could be envisioned as the situation in V pre-B1 -deficient mice while a major (20 to 40-fold) reduction in pre-B(II) cells is compatible with that found in mice lacking λ5 that also have a significant decrease in the number of peripheral B cells.
Our data herein shows that mice expressing only one V pre-B gene (V pre-B2 ) are immunocompetent and give rise to both hapten-and carrier-specific antibodies when challenged with T cell-dependent antigens. Thus, in mice, as is the case in humans, one V pre-B gene is sufficient, if not as efficient. 
